5AM Ventures VI, L.P.
SEC CIK 1753037 · EDGAR
BoughtSold
Most active insiders at LTGO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foresite Capital Management V, LLC | 10% | $2.52M | — |
| 2 | Tananbaum James B. | Dir, 10% | $2.52M | — |
| 3 | 5AM Ventures VI, L.P. | 10% | — | — |
| 4 | Westlake BioPartners Fund I, L.P. | 10% | — | — |
| 5 | SEIDENBERG BETH C | Dir, 10% | — | — |
| 6 | Sanofi | 10% | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-08-12 16:13 | 2026-08-10 | LTGO | Latigo Biotherapeutics, Inc. | 5AM Ventures VI, L.P. | 10% | C - Cnv Deriv | — | +7.33M | 2.35M | New | — |
| MI | 2024-02-16 | 2024-02-14 | ELVN | Enliven Therapeutics, Inc. | 5AM Ventures VI, L.P. | 10% | S - Sale | $14.90 | -825.0K | 3.20M | -20% | -$12.29M |
Purchase Sale Sale after option exercise All abbreviations